Volume 13, Number 1—January 2007
Research
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Rebecca H. Sunenshine*, Marc-Oliver Wright†, Lisa L. Maragakis‡, Anthony D. Harris†, Xiaoyan Song‡, Joan Hebden†, Sara E. Cosgrove‡, Ashley Anderson*, Jennifer Carnell*, Daniel B. Jernigan*, David G. Kleinbaum*, Trish M. Perl‡, Harold C. Standiford†, and Arjun Srinivasan*
Table 2
Matched univariate analysis comparing outcomes of patients with multidrug-resistant (MDR) Acinetobacter infection with those with susceptible Acinetobacter infection and those without Acinetobacter infection, Baltimore hospitals, 2003–2004
| Outcome evaluated | MDR Acinetobacter, n = 96 | Susceptible Acinetobacter, n = 91 | p values for MDR Acinetobacter vs. susceptible, n = 182 | Uninfected, n = 89 | p values for MDR Acinetobacter vs. uninfected, n = 178 |
|---|---|---|---|---|---|
| Mean length of stay after index day, d | 27.5 | 19.8 | 0.02 | 18.6 | <0.01 |
| Mean intensive care unit length of stay after index day, d | 13.3 | 6.7 | 0.04 | 7.3 | <0.01 |
| Mortality rate (%) | 26.0 | 17.6 | 0.21 | 11.2 | <0.01 |
